The nature of cancer control is changing, with an increasing emphasis, fuelled by public and
political demand, on prevention, early diagnosis, and patient experience during and after …

Prostate cancer is a common malignancy seen worldwide. The incidence has risen in recent
decades, mainly fuelled by more widespread use of prostate-specific antigen (PSA) testing, …

Background Prostate-specific antigen (PSA) is a commonly used test to detect prostate cancer.
Attention has mostly focused on the use of PSA in screening asymptomatic patients, but …

Many patients with cancer are diagnosed through an emergency presentation, which is
associated with inferior clinical and patient-reported outcomes compared with those of patients …

Background Corticosteroid injections and physiotherapy exercise programmes are commonly
used to treat rotator cuff disorders but the treatments' effectiveness is uncertain. We aimed …

Background The serum biomarker cancer antigen 125 (CA125) is widely used as an
investigation for possible ovarian cancer in symptomatic women presenting to primary care. …

Oesophageal cancers (adenocarcinomas [AC] and squamous cell carcinomas [SCC]) are
characterized by high incidence/mortality in many countries. We aimed to delineate its global …

Background The UK lags behind many European countries in terms of cancer survival. Initiatives
to address this disparity have focused on barriers to presentation, symptom recognition, …

An earlier diagnosis is a key strategy for improving the outcomes of patients with cancer.
However, achieving this goal can be challenging, particularly for the growing number of people …

Objectives The International Cancer Benchmarking Partnership (ICBP) is a collaboration
between 6 countries and 12 jurisdictions with similar primary care-led health services. This …